Authors: FRIDRIK MA GREIL R HAUSMANINGER H KRIEGER O OPPITZ P STOGER M KLOCKER J NEUBAUER M HELM W PONT J FAZENY B HUDEC M SIMONITSCH I RADASZKIEWICZ T

Citation: Ma. Fridrik et al., RANDOMIZED OPEN-LABEL PHASE-III TRIAL OF CEOP IMVP-DEXA ALTERNATING CHEMOTHERAPY AND FILGRASTIM VERSUS CEOP/IMVP-DEXA ALTERNATING CHEMOTHERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - A MULTICENTER TRIAL BY THE AUSTRIAN WORKING GROUP FOR MEDICAL TUMOR-THERAPY/, Annals of hematology, 75(4), 1997, pp. 135-140

Authors: THALER J HILBE W APFELBECK U LINKESCH W SILL H SEEWANN H PONT J BERNHART M STOGER M NIESSNER H ABBREDERIS K GEISSLER D HAUSMANINGER H LIN W LUDWIG H LANG A DUBA C FLUCKINGER T GREIL R GRUNEWALD K KONWALINKA G NIEDERWIESER D FRIDRIK M

Citation: J. Thaler et al., INTERFERON-ALPHA-2C AND LD ARA-C FOR THE TREATMENT OF PATIENTS WITH CML - RESULTS OF THE AUSTRALIAN MULTICENTER PHASE-II STUDY, Leukemia research, 21(1), 1997, pp. 75-80

Authors: FRIDRIK MA HAUSMANINGER H LINKESCH W STOGER M SILL H NEUBAUER M SEEWANN HL KLOCKER J HAIDINGER R SCHILLER L PONT J RAUDASCHL G FOLK M RADASZKIEWICZ T

Citation: Ma. Fridrik et al., CEOP-IMVP-DEXA IN THE TREATMENT OF AGGRESSIVE LYMPHOMAS - AN AUSTRIANMULTICENTER TRIAL, Journal of clinical oncology, 14(1), 1996, pp. 227-232

Authors: FRIDRIK MA GREIL R HAUSMANINGER H KRIEGER O OPPITZ P STOGER M KLOCKER J NEUBAUER M DITTRICH C HELM W

Citation: Ma. Fridrik et al., VALUE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF) IN THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL)WITH AN INTENSIVE WEEKLY CHEMOTHERAPY SCHEDULE - AN AUSTRIAN RANDOMIZED MULTICENTER TRIAL, Blood, 84(10), 1994, pp. 10000023-10000023